• Immunomodulator Platform
• Stradomer^TM Platform
• Stradomer^TM-coated Device Platform
• Stradobody^TM Platform

The Stradomer^TM Platform

GL-2045 is Gliknik's lead recombinant stradomer^TM for autoimmune diseases. It has demonstrated potent efficacy in numerous animal models. Stradomers^TM are recombinant compounds designed to improve on both pooled human intravenous immunoglobulin and also on antibody therapies used in immune disorders such as rheumatoid arthritis.